736 results on '"Wentworth, David E."'
Search Results
2. When to update COVID-19 vaccine composition
3. Timing of seasonal influenza epidemics for 25 countries in Africa during 2010–19: a retrospective analysis
4. SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States
5. United States Centers for Disease Control and Prevention support for influenza surveillance, 2013-2021/Aide apportee par les Centers for Disease Control and Prevention des Etats-Unis d'Amerique dans la surveillance des grippes, 2013-2021/Apoyo de los Centros para el Control y la Prevencion de Enfermedades de Estados Unidos a la vigilancia de la gripe, 2013-2021
6. Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
7. An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
8. Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
9. Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
10. Defining the risk of SARS-CoV-2 variants on immune protection
11. Influenza
12. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
13. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
14. In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019
15. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021
16. Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
17. Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2
18. Targeted amplification and genetic sequencing of the severe acute respiratory syndrome coronavirus 2 surface glycoprotein
19. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
20. Update : Influenza Activity — United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine
21. Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses
22. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages--United States, January 2022-May 2023
23. Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas
24. SARS-CoV-2 spike D614G change enhances replication and transmission
25. N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry
26. Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
27. Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies
28. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
29. Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS‐CoV‐2
30. Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
31. Update : Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza Vaccine
32. Update : Influenza Activity — United States, September 30, 2018–February 2, 2019
33. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
34. Influenza Activity — United States, September 30–December 1, 2018
35. Update : Influenza Activity — United States and Worldwide, May 20–October 13, 2018
36. Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
37. Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence
38. Global migration of influenza A viruses in swine.
39. Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells
40. Comparison of nucleic acid extraction methods for next-generation sequencing of avian influenza A virus from ferret respiratory samples
41. Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages.
42. Reported Global Avian Influenza Detections Among Humans and Animals During 2013-2022: Comprehensive Review and Analysis of Available Surveillance Data
43. Targeted Amplification and Genetic Sequencing of the Severe Acute Respiratory Syndrome Coronavirus 2 Surface Glycoprotein
44. Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2
45. Non-mumps Viral Parotitis During the 2014–2015 Influenza Season in the United States
46. Influenza-Associated Parotitis During the 2014–2015 Influenza Season in the United States
47. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013
48. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
49. Update : Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
50. Update : Influenza Activity — United States, October 1, 2017–February 3, 2018
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.